Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3865950 | The Journal of Urology | 2010 | 9 Pages |
Abstract
The risk of coronary thrombosis when antiplatelet agents are withdrawn before surgery is generally higher than the risk of surgical hemorrhage when antiplatelet agents are maintained. However, this issue has not yet been sufficiently evaluated in urological patients and in many instances during urological surgery the risk of bleeding can be dangerous. A thorough dialogue among surgeon, cardiologist and anesthesiologist is essential to determine all risk factors and define the best possible strategy for each patient.
Keywords
RRRACSBMSPCIMyocardial infarctionDESBlood lossStentsdrug-eluting stentbare metal stentTransurethral resection of the prostateProstate biopsySurgicalCABGAcute coronary syndromeTURPMyocardial revascularizationAntiplatelet agentspercutaneous coronary interventionplatelet aggregation inhibitorsCoronary artery bypass graftrelative risk reduction
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Daniel Eberli, Pierre-Guy Chassot, Tullio Sulser, Charles Marc Samama, Jean Mantz, Alain Delabays, Donat R. Spahn,